Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 682019, 9 pages
http://dx.doi.org/10.1155/2015/682019
Research Article

Orostachys japonicus Inhibits Expression of the TLR4, NOD2, iNOS, and COX-2 Genes in LPS-Stimulated Human PMA-Differentiated THP-1 Cells by Inhibiting NF-κB and MAPK Activation

Department of Internal Medicine, College of Korean Medicine, Kyung Hee University, Seoul 130-872, Republic of Korea

Received 30 September 2014; Revised 20 January 2015; Accepted 26 January 2015

Academic Editor: Alfredo Vannacci

Copyright © 2015 Yeo-Kwang Yoon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Ma, W. J. Jung, K. Y. Lee, Y. C. Kim, and S. H. Sung, “Calpain inhibitory flavonoids isolated from Orostachys japonicus,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 3, pp. 676–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. J. Park, S. H. Moon, K. Y. Park et al., “Antimutagenic effect of Orostachys japonicus,” Journal of the Pharmaceutical Society of Korea, vol. 35, pp. 253–257, 1991. View at Google Scholar
  3. J.-H. Jeong, D.-S. Ryu, D.-H. Suk, and D.-S. Lee, “Anti-inflammatory effects of ethanol extract from Orostachys japonicus on modulation of signal pathways in LPS-stimulated RAW 264.7 cells,” BMB Reports, vol. 44, no. 6, pp. 399–404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Akira and H. Hemmi, “Recognition of pathogen-associated molecular patterns by TLR family,” Immunology Letters, vol. 85, no. 2, pp. 85–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Sabroe, R. C. Read, M. K. B. Whyte, D. H. Dockrell, S. N. Vogel, and S. K. Dower, “Toll-like receptors in health and disease: complex questions remain,” The Journal of Immunology, vol. 171, no. 4, pp. 1630–1635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. N. Cook, D. S. Pisetsky, and D. A. Schwartz, “Toll-like receptors in the pathogenesis of human disease,” Nature Immunology, vol. 5, no. 10, pp. 975–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Strober, P. J. Murray, A. Kitani, and T. Watanabe, “Signalling pathways and molecular interactions of NOD1 and NOD2,” Nature Reviews Immunology, vol. 6, no. 1, pp. 9–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Medzhitov, “Toll-like receptors and innate immunity,” Nature Reviews Immunology, vol. 1, no. 2, pp. 135–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. M. Barton and R. Medzhitov, “Toll-like receptor signaling pathways,” Science, vol. 300, no. 5625, pp. 1524–1525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Lee and Y.-J. Kim, “Signaling pathways downstream of pattern-recognition receptors and their cross talk,” Annual Review of Biochemistry, vol. 76, pp. 447–480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Kim and Y. K. Cho, “Pattern recognition receptors in immune modulation,” Biowave, vol. 8, pp. 1–22, 2006. View at Google Scholar
  14. D. C. Rockey, J. J. Chung, C. M. McKee, and P. W. Noble, “Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments,” Hepatology, vol. 27, no. 1, pp. 86–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Giuliani, G. Napolitano, I. Bucci, V. Montani, and F. Monaco, “NF-κB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications,” Clinica Terapeutica, vol. 152, no. 4, pp. 249–253, 2001. View at Google Scholar
  16. J.-B. Méric, S. Rottey, K. Olaussen et al., “Cyclooxygenase-2 as a target for anticancer drug development,” Critical Reviews in Oncology/Hematology, vol. 59, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Barnes and M. Karin, “Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. E. Choi, H. Ahn, and J.-H. Ryu, “Polyacetylenes from Angelica gigas and their inhibitory activity on nitric oxide synthesis in activated macrophages,” Biological & Pharmaceutical Bulletin, vol. 23, no. 7, pp. 884–886, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-H. Kim, J.-H. Jeong, S.-T. Jeon et al., “Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-κB activation in macrophages,” Molecular Pharmacology, vol. 69, no. 6, pp. 1783–1790, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Underhill and A. Ozinsky, “Toll-like receptors: key mediators of microbe detection,” Current Opinion in Immunology, vol. 14, no. 1, pp. 103–110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Dugan, A. Albor, L. David et al., “Nucleotide oligomerization domain-2 interacts with 2′-5′-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells,” Molecular Immunology, vol. 47, no. 2-3, pp. 560–566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-J. Surh, K.-S. Chun, H.-H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. H. S. Ban, S. S. Lim, K. Suzuki et al., “Inhibitory effects of furanocoumarins isolated from the roots of Angelica dahurica on prostaglandin E2 production,” Planta Medica, vol. 69, no. 5, pp. 408–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Lin, S. T. Huang, Y. C. Liang et al., “Isovitexin suppresses lipopolysaccharide-mediated inducible nitric oxide synthase through inhibition of NF-kappa B in mouse macrophages,” Planta Medica, vol. 71, no. 8, pp. 748–753, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-H. Jang, S. Lim, S.-M. Han et al., “Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929,” Journal of Pharmacological Sciences, vol. 93, no. 3, pp. 367–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. B. L. Fiebich, M. Heinrich, K. O. Hiller, and N. Kammerer, “Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69,” Phytomedicine, vol. 8, no. 1, pp. 28–30, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-B. Ahn and J.-Y. Je, “Anti-inflammatory activity of the oriental herb medicine, Arisaema cum Bile, in LPS-induced PMA-differentiated THP-1 cells,” Immunopharmacology and Immunotoxicology, vol. 34, no. 3, pp. 379–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-S. Lee, D.-S. Ryu, G.-S. Lee, and D.-S. Lee, “Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: suppression of NF-κB activation and MAPK signaling,” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 271–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. T. H.-W. Huang, V. H. Tran, R. K. Duke et al., “Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 149–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-S. Lai, J. H. Lee, C.-T. Ho et al., “Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-κB, STAT3 and C/EBP signaling pathways,” Journal of Agricultural and Food Chemistry, vol. 57, no. 22, pp. 10990–10998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Tang, X.-Y. Shen, H.-Q. Huang et al., “Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-κB and MAPK signaling pathways,” Inflammation, vol. 34, no. 2, pp. 111–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. Dhillon, S. Hagan, O. Rath, and W. Kolch, “MAP kinase signalling pathways in cancer,” Oncogene, vol. 26, no. 22, pp. 3279–3290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Lawrence and C. Fong, “The resolution of inflammation: anti-inflammatory roles for NF-κB,” The International Journal of Biochemistry and Cell Biology, vol. 42, no. 4, pp. 519–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Hayden and S. Ghosh, “Shared principles in NF-κB signaling,” Cell, vol. 132, no. 3, pp. 344–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. E. K. Kim and E.-J. Choi, “Pathological roles of MAPK signaling pathways in human diseases,” Biochimica et Biophysica Acta, vol. 1802, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus